Note: Not all species have been tested for usefulness with this product. Only those species listed have been tested. We cannot make any guarantees about additional reactivities which may or may not occur.
Full length human KLK6 protein [Swiss-Prot# Q92876] expressed in E. coli.
Localization:
Secreted. Nucleus ? nucleolus. Cytoplasm. Mitochondrion. Microsome. Note= In brain, detected in the nucleus of glial cells and in the nucleus and cytoplasm of neurons. Detected in the mitochondrial and microsomal fractions of HEK-293 cells and released in
Species Reactivity:
Human. Sequence has 85% identity with canine, 82% identity with horse and 80% identity with bovine.
Applications:
Uses:
This antibody is useful for Western blot, where a band is seen ~38kDa due to glycosylation.
Store at 4 °C short term. Aliquot and store at -20 °C long term. Avoid freeze-thaw cycles.
Buffer:
Whole sera
Preservative:
0.1% Sodium Azide
Limitations:
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Products are guaranteed for 6 months from date of receipt, except for peptides and proteins which are guaranteed for 3 months.
Kallikreins are a subgroup of serine proteases having diverse physiological functions. Kallikrein 6, or KLK6, shows activity against amyloid precursor protein, myelin basic protein, gelatin, casein and extracellular matrix proteins such as fibronectin, laminin, vitronectin and collagen. It degrades alpha-synuclein and prevents its polymerization, indicating that it may be involved in the pathogenesis of Parkinson disease and other synucleinopathies. KLK6 may be involved in regulation of axon outgrowth following spinal cord injury. KLK6 has also been shown to promote cell proliferation, migration, and invasion and is upregulated in several types of cancers including colon and ovarian cancers.
Henkhaus RS et al. Caveolin-1-mediated expression secretion of kallikrein 6 in colon cancer cells. Neoplasia 10(2):140-8 (2008)
Kuzmanov U, et al. Differential n-glycosylation of kallikrein 6 derived from ovarian cancer cells or the central nervous system. Mol Cell Proteomics. [Epub ahead of print] (Dec. 2008)